Form 8.5 (EPT/RI) Mediclinic

Jul 06 2022 12:56 BSTSource: RNS

RNS Number : 5414R

UBS AG (EPT)

06 July 2022

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the Code)

1. KEY INFORMATION

(a) Name of exempt principal trader:	UBS Investment Bank, London
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree	Mediclinic International plc
(c) Name of the party to the offer with which exempt principal trader is connected:	Mediclinic International plc
(d) Date dealing undertaken:	05 July 2022
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state "N/A"	NO

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

10p ordinary

Buy

347,317

4.64156

GBP

4.43000 GBP

10p ordinary

Sell

328,477

4.63405

GBP

4.44099 GBP

(b) Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position	Number of reference securities	Price per unit
10p ordinary	CFD	Long	34	4.483765 GBP
10p ordinary	CFD	Long	9665	87.95489757 ZAR
10p ordinary	CFD	Long	1374	87.91696507 ZAR
10p ordinary	CFD	Long	2933	89.29686669 ZAR
10p ordinary	CFD	Long	359	88.83272981 ZAR
10p ordinary	CFD	Long	8167	89.08238582 ZAR
10p ordinary	CFD	Long	14725	4.46 GBP
10p ordinary	CFD	Long	318	4.51948693710692 GBP
10p ordinary	CFD	Long	1005	4.517455 GBP
10p ordinary	CFD	Long	5226	4.465414 GBP
10p ordinary	CFD	Long	132	4.456327 GBP
10p ordinary	CFD	Long	743	4.476541 GBP
10p ordinary	CFD	Long	17	4.451412 GBP
10p ordinary	CFD	Long	1104	4.45138815 GBP
10p ordinary	CFD	Long	2021	4.450941 GBP
10p ordinary	CFD	Short	32	4.64125 GBP
10p ordinary	CFD	Short	7434	4.457629 GBP
10p ordinary	CFD	Short	2419	4.520496 GBP
10p ordinary	CFD	Short	79	4.484 GBP
10p ordinary	CFD	Short	1896	4.452166 GBP
10p ordinary	CFD	Short	5132	4.473684 GBP
10p ordinary	CFD	Short	2798	4.448105 GBP
10p ordinary	CFD	Short	1011	4.4549 GBP
10p ordinary	CFD	Short	44	4.452089 GBP
10p ordinary	CFD	Short	1374	87.91696507 ZAR
10p ordinary	CFD	Short	359	88.83272981 ZAR
10p ordinary	CFD	Short	1558	89.2957317073171 ZAR
10p ordinary	CFD	Short	1375	89.2981527272727 ZAR
10p ordinary	CFD	Short	17046	4.444207 GBP
10p ordinary	CFD	Short	8167	89.08238582 ZAR
10p ordinary	CFD	Short	9665	87.95489757 ZAR

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none "

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

Date of disclosure:	06 July 2022
Contact name:	Richard Howard
Telephone number:	+44 (0)207 568 9128

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

FERRFMMTMTAMBIT

Company Announcements

Form 8.5 (EPT/RI) Mediclinic

Date of disclosure:

Contact name:

Telephone number: